Autoimmunity and longevity: presence of antinuclear antibodies is not associated with the rate of inflammation or mortality in nonagenarians.
There are reports demonstrating elevated levels of autoantibodies in elderly people. We now analyzed whether the strong inflammatory response associated with aging is interrelated with the production of autoantibodies, antinuclear antibodies (ANA). In a cohort of 284 nonagenarians the rate of ANA positivity was 12.3%, which is significantly (p<0.001) higher than that in the middle-aged controls (2.8%). The mortality data of this cohort was collected after a 4-year follow-up. The ANA positivity at the age of 90 did not have any effect on the rate of survival, or on the levels of serum markers of inflammation.
Hurme
M
M
Department of Microbiology and Immunology, University of Tampere Medical School, Finland. mikko.hurme@uta.fi
Korkki
S
S
Lehtimäki
T
T
Karhunen
P J
PJ
Jylhä
M
M
Hervonen
A
A
Pertovaara
M
M
D000369:Aged, 80 and over; D000974:Antibodies, Antinuclear / Q000097:blood*; D015551:Autoimmunity / Q000276:immunology*; D006801:Humans; D007249:Inflammation / Q000097:blood; D008136:Longevity / Q000276:immunology*; D009026:Mortality
D000974:Antibodies, Antinuclear